Experimental and Molecular Medicine

Korean Society for Biochemistry and Molecular Biongy (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis

Seo, Geom-Seog;Lee, Jeong-Kun;Yu, Ji-In;Yun, Ki-Jung;Chae, Soo-Cheon;Choi, Suck-Chei

  • Published : 20100200
⟨ Previous Next ⟩

Abstract

Interferons play critical roles in tumor pathogenesis by controlling apoptosis and through cellular anti-proliferative and differentiation activities. Interferon inducible transmembrane protein (IFITM) family genes have been implicated in several cellular processes such as the homotypic cell adhesion functions of IFN and cellular anti-proliferative activities. expression levels of IFITM genes have been found to be up-regulated in gastric cancer cells and colorectal tumors. IFITM3 (also known as 1-8U) is a member of the IFITM family, and has been described as a key player in specification of germ cell fate. IFITM3 was first isolated from a genetic screen aimed at identifying genes involved in acquisition of germ cell competence. It has been proposed that epiblast cells have the highest expression of IFITM3 initiated germ cell specification and that homotypic association can discriminate germ cells from their somatic neighbors. In an attempt to better understand the genetic influences of IFITM3 on ulcerative colitis, we have identified possible variation sites and single nucleotide polymorphisms (SNPs) through two exons and their boundary IFITM3 intron sequences including the ${\sim}$2.1 kb promoter regions. To determine whether or not these IFITM3 SNPs are associated with susceptibility to ulcerative colitis, frequencies of the genotype and allele of IFITM3 polymorphisms were analyzed on genomic DNAs isolated from patients with ulcerative colitis and from healthy controls. We also investigated the haplotype frequencies constructed by these SNPs in both groups. In this study, we also showed that expression level of IFITM3 mRNA was significantly higher in tissues of the ileum and cecum of the digestive system. We identified a total of seven SNPs and multiple variation regions in the IFITM3 gene. The genotype frequency of the g.-204T＞G polymorphism in patients with ulcerative colitis was significantly different from that of the control group. Our results strongly suggest that polymorphisms of the IFITM3 gene may be associated with susceptibility to ulcerative colitis.

Keywords

References

  1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93 https://doi.org/10.1038/383787a0
  2. Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004;126:1533-49 https://doi.org/10.1053/j.gastro.2004.01.061
  3. Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, Perret C, Romagnolo B. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 2006;66:1949-55 https://doi.org/10.1158/0008-5472.CAN-05-2731
  4. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11: 648-56 https://doi.org/10.1016/S0952-7915(99)00032-1
  5. Chae SC, Song JH, Pounsambath P, Yuan HY, Lee JH, Kim JJ, Lee YC, Chung HT. Molecular variations in Th1-specific cell surface gene Tim-3. Exp Mol Med 2004;36:274-8 https://doi.org/10.1038/emm.2004.37
  6. Dechairo B, Dimon C, van Heel D, Mackay I, Edwards M, Scambler P, Jewell D, Cardon L, Lench N, Carey A. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet 2001;9:627-33 https://doi.org/10.1038/sj.ejhg.5200687
  7. Farrell RJ. Ulcerative colitis. Lancet 2002;359:331-40 https://doi.org/10.1016/S0140-6736(02)07499-8
  8. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205 https://doi.org/10.1016/S0016-5085(98)70381-6
  9. Forbes A. Clinical presentation and diagnosis of Crohn's disease. In: Satsangi J and Sutherland L, eds. Inflammatory Bowel Disease. New York: Churchill Livingstone, 2003: 183-9
  10. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984;38:745-55 https://doi.org/10.1016/0092-8674(84)90270-8
  11. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-$\gamma$, whereas, ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70
  12. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, N$\"{u}$rnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999;64:808-16 https://doi.org/10.1086/302294
  13. Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, and Hibi T. Interferon-inducible Gene Family 1-8U Expression in Colitis-associated Colon Cancer and Severely Inflamed Mucosa in Ulcerative Colitis. Cancer Res 1999;59: 5927-31
  14. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules differentially activate the TH1/TH2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-16 https://doi.org/10.1016/0092-8674(95)90349-6
  15. Lange UC, Saitou M, Western PS, Barton SC, Surani MA. The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 2003;3:1 https://doi.org/10.1186/1471-213X-3-1
  16. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 1991;199:417-23 https://doi.org/10.1111/j.1432-1033.1991.tb16139.x
  17. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73 https://doi.org/10.1146/annurev.iy.07.040189.001045
  18. Nayar M, Rhodes JM. Management of inflammatory bowel disease. Postgrad Med J 2004;80:206-13 https://doi.org/10.1136/pgmj.2003.013722
  19. Park YR, Choi SC, Lee ST, Kim KS, Chae SC, Chung HT. The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp Mol Med 2005;37:553-8 https://doi.org/10.1038/emm.2005.68
  20. Parkes M, Barmada MM, Satsangi J, Weeks DE, Jewell DP, Duerr RH. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet 2000;67:1605-10 https://doi.org/10.1086/316905
  21. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-82
  22. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29 https://doi.org/10.1056/NEJMra020831
  23. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212-7 https://doi.org/10.1016/S0140-6736(96)90734-5
  24. Song JH, Choi SC, Lee ST, Lee JH, Chae SC, Chung HT. The exon 4 variations of Tim-1 gene is not associated with allergic rhinitis and ulcerative colitis in Koreans. Korean J Genetics 2004;26:193-7
  25. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a metaanalysis. Gut 1999;45:395-401 https://doi.org/10.1136/gut.45.3.395
  26. Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PP. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 2005;9:745-56 https://doi.org/10.1016/j.devcel.2005.10.010
  27. Targan SR, Deem RL, Liu M, Wang S, Nel A. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995;154:664-75
  28. Travis S, Jewell DP. Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J and Sutherland LR, eds. Inflammatory Bowel Disease. New York: Churchill Livingstone, 2003:169-82
  29. Van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004;13:763-70 https://doi.org/10.1093/hmg/ddh090
  30. Williams CN, Kocher K, Lander ES, Daly MJ, Rioux JD. Using a genome-wide scan and meta-analysis to identify IBD loci. Inflamm Bowel Dis 2002;8:375-81 https://doi.org/10.1097/00054725-200211000-00001
  31. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. Genome-wide Gene Expression Differences in Crohn's Disease and Ulcerative Colitis from Endoscopic Pinch Biopsies: Insights into Distinctive Pathogenesis. Inflamm Bowel Dis 2007;13: 807-21 https://doi.org/10.1002/ibd.20110
  32. Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, Targan SR, Rotter JI. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 1999;44:519-26 https://doi.org/10.1136/gut.44.4.519
  33. Yang Y, Lee JH, Kim KY, Song HK, Kim JK, Yoon SR, Cho D, Song KS, Lee YH, Choi I. The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 2005; 221:191-200 https://doi.org/10.1016/j.canlet.2004.08.022

Cited by

  1. The Small Interferon-Induced Transmembrane Genes and Proteins vol.31, pp.1, 2010, https://doi.org/10.1089/jir.2010.0112
  2. Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes vol.113, pp.3, 2012, https://doi.org/10.1002/jcb.23412
  3. Associations of IFITM3 haplotypes with rheumatoid arthritis in a Korean population vol.34, pp.5, 2010, https://doi.org/10.1007/s13258-011-0241-8
  4. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function vol.18, pp.6, 2012, https://doi.org/10.1177/1753425912443392
  5. The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients vol.44, pp.2, 2010, https://doi.org/10.3858/emm.2012.44.2.010
  6. The role of IFITM3 in the growth and migration of human glioma cells vol.13, pp.None, 2010, https://doi.org/10.1186/1471-2377-13-210
  7. A Functional Promoter Polymorphism of IFITM3 Is Associated with Susceptibility to Pediatric Tuberculosis in Han Chinese Population vol.8, pp.7, 2010, https://doi.org/10.1371/journal.pone.0067816
  8. Novel genomic biomarkers for acute gentamicin nephrotoxicity in dog vol.3, pp.3, 2010, https://doi.org/10.4236/ojmip.2013.33018
  9. Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis vol.156, pp.1, 2013, https://doi.org/10.1016/j.imlet.2013.09.026
  10. IFITMs Restrict the Replication of Multiple Pathogenic Viruses vol.425, pp.24, 2010, https://doi.org/10.1016/j.jmb.2013.09.024
  11. HIV-1 mutates to evade IFITM1 restriction vol.454, pp.None, 2014, https://doi.org/10.1016/j.virol.2014.01.020
  12. Identification of the Polymorphisms in IFITM2 and IFITM5 Genes and their Association with Ulcerative Colitis vol.25, pp.1, 2010, https://doi.org/10.5352/jls.2015.25.1.84
  13. Identification of differentially expressed transcripts targeted by the knockdown of endogenous IFITM3 vol.14, pp.5, 2010, https://doi.org/10.3892/mmr.2016.5777
  14. Significant association of the GABRP polymorphisms with ulcerative colitis patients vol.39, pp.3, 2010, https://doi.org/10.1007/s13258-017-0514-y
  15. Characterization and anti-inflammation role of swine IFITM3 gene vol.8, pp.43, 2010, https://doi.org/10.18632/oncotarget.20568
  16. The anti‐inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota vol.96, pp.3, 2010, https://doi.org/10.1111/imcb.12000
  17. Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma vol.98, pp.2, 2010, https://doi.org/10.1097/md.0000000000013996
  18. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells vol.42, pp.4, 2010, https://doi.org/10.1007/s13402-019-00437-z
  19. Genetic characteristics and polymorphisms in the chicken interferon-induced transmembrane protein ( IFITM3 ) gene vol.43, pp.4, 2019, https://doi.org/10.1007/s11259-019-09762-y
  20. Malignancy and IFITM3: Friend or Foe? vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.593245
  21. Phylogenetic and topological analyses of the bovine interferon-induced transmembrane protein (IFITM3) vol.69, pp.1, 2010, https://doi.org/10.1556/004.2021.00010
  22. Phylogenetic and topological analyses of the bovine interferon-induced transmembrane protein (IFITM3) vol.69, pp.1, 2010, https://doi.org/10.1556/004.2021.00010